NAPHTYRIDINES UTILISES EN TANT QU'INHIBITEURS DE HPK1

• 收藏
• 分享

专利权人:

F.HOFFMANN-LA ROCHE AG

发明人:

CHAN, BRYAN,DANIELS, BLAKE,DROBNICK, JOY,GAZZARD, LEWIS,HEFFRON, TIMOTHY,HUESTIS, MALCOLM,LIANG, JUN,MALHOTRA, SUSHANT,MENDONCA, ROHAN,RAJAPAKSA, NAOMI,SIU, MICHAEL,STIVALA, CRAIG,TELLIS, JOHN,WANG, W

申请号：

CA3052492

公开号：

CA3052492A1

申请日:

2018.03.30

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibitng HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/